Movatterモバイル変換


[0]ホーム

URL:


EP1770161A3 - BMP-11 compositions - Google Patents

BMP-11 compositions
Download PDF

Info

Publication number
EP1770161A3
EP1770161A3EP06022258AEP06022258AEP1770161A3EP 1770161 A3EP1770161 A3EP 1770161A3EP 06022258 AEP06022258 AEP 06022258AEP 06022258 AEP06022258 AEP 06022258AEP 1770161 A3EP1770161 A3EP 1770161A3
Authority
EP
European Patent Office
Prior art keywords
bmp
compositions
proteins
useful
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06022258A
Other languages
German (de)
French (fr)
Other versions
EP1770161A2 (en
Inventor
Anthony Joseph Celeste
John Martin Wozney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLCfiledCriticalGenetics Institute LLC
Priority to EP10181708ApriorityCriticalpatent/EP2272959A1/en
Publication of EP1770161A2publicationCriticalpatent/EP1770161A2/en
Publication of EP1770161A3publicationCriticalpatent/EP1770161A3/en
Withdrawnlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

Purified BMP-11 proteins and processes for producing them are disclosed. The proteins may be useful in increasing neuronal cell survival.
EP06022258A1993-05-121994-05-12BMP-11 compositionsWithdrawnEP1770161A3 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
EP10181708AEP2272959A1 (en)1993-05-121994-05-12BMP-11 compositions

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US6146493A1993-05-121993-05-12
EP03021107AEP1378572B1 (en)1993-05-121994-05-12Bmp-11 compositions
EP94917361AEP0698094B1 (en)1993-05-121994-05-12Bmp-11 compositions

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
EP03021107ADivisionEP1378572B1 (en)1993-05-121994-05-12Bmp-11 compositions

Publications (2)

Publication NumberPublication Date
EP1770161A2 EP1770161A2 (en)2007-04-04
EP1770161A3true EP1770161A3 (en)2008-04-23

Family

ID=22035966

Family Applications (4)

Application NumberTitlePriority DateFiling Date
EP06022258AWithdrawnEP1770161A3 (en)1993-05-121994-05-12BMP-11 compositions
EP10181708AWithdrawnEP2272959A1 (en)1993-05-121994-05-12BMP-11 compositions
EP03021107AExpired - LifetimeEP1378572B1 (en)1993-05-121994-05-12Bmp-11 compositions
EP94917361AExpired - LifetimeEP0698094B1 (en)1993-05-121994-05-12Bmp-11 compositions

Family Applications After (3)

Application NumberTitlePriority DateFiling Date
EP10181708AWithdrawnEP2272959A1 (en)1993-05-121994-05-12BMP-11 compositions
EP03021107AExpired - LifetimeEP1378572B1 (en)1993-05-121994-05-12Bmp-11 compositions
EP94917361AExpired - LifetimeEP0698094B1 (en)1993-05-121994-05-12Bmp-11 compositions

Country Status (16)

CountryLink
US (7)US5639638A (en)
EP (4)EP1770161A3 (en)
JP (2)JP3681069B2 (en)
KR (1)KR100227406B1 (en)
AT (2)ATE343635T1 (en)
AU (1)AU678582B2 (en)
BR (1)BR9406715A (en)
CA (1)CA2161808C (en)
DE (2)DE69433530T2 (en)
DK (2)DK0698094T3 (en)
ES (2)ES2274157T3 (en)
FI (1)FI119696B (en)
NO (1)NO320119B1 (en)
OA (1)OA10191A (en)
PT (2)PT1378572E (en)
WO (1)WO1994026892A1 (en)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE20004692U1 (en)2000-03-142001-07-26Sofamor Danek GmbH, 94469 Deggendorf Vertebral implant for screwing into an intervertebral space
US6150328A (en)1986-07-012000-11-21Genetics Institute, Inc.BMP products
ATE238417T1 (en)*1991-11-042003-05-15Inst Genetics Llc RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE
US20080139474A1 (en)*1991-11-042008-06-12David IsraelRecombinant bone morphogenetic protein heterodimers, compositions and methods of use
US7393682B1 (en)*1993-03-192008-07-01The Johns Hopkins University School Of MedicinePolynucleotides encoding promyostatin polypeptides
US20030074680A1 (en)*1993-03-192003-04-17Johns Hopkins University School Of MedicineGrowth differentiation factor-8
US6465239B1 (en)*1993-03-192002-10-15The John Hopkins University School Of MedicineGrowth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
ES2274157T3 (en)*1993-05-122007-05-16Genetics Institute, Llc BMP-11 COMPOSITIONS.
US6291206B1 (en)1993-09-172001-09-18Genetics Institute, Inc.BMP receptor proteins
ATE319823T1 (en)1993-12-072006-03-15Inst Genetics Llc BMP-12, BMP-13 AND TENDON-INDUCING COMPOSITIONS CONTAINING SAME
US5942496A (en)1994-02-181999-08-24The Regent Of The University Of MichiganMethods and compositions for multiple gene transfer into bone cells
US6551618B2 (en)1994-03-152003-04-22University Of BirminghamCompositions and methods for delivery of agents for neuronal regeneration and survival
US7332575B2 (en)*1994-03-182008-02-19The Johns Hopkins University School Of MedicineGrowth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
US5906827A (en)*1994-06-031999-05-25Creative Biomolecules, Inc.Matrix for the manufacture of autogenous replacement body parts
US20030167492A1 (en)1994-07-082003-09-04Johns Hopkins University School Of MedicineTransgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
US6008434A (en)1994-07-081999-12-28Johns Hopkins University School Of MedicineGrowth differentiation factor-11 transgenic mice
ES2251721T3 (en)*1994-07-082006-05-01The Johns Hopkins University School Of Medicine GROWTH DIFFERENTIATION FACTOR-11.
US5846770A (en)*1994-11-221998-12-08Genetics Institute, Inc.DNA molecules encoding human chordin
US5645084A (en)*1995-06-071997-07-08Danek Medical, Inc.Method for spinal fusion without decortication
US5635372A (en)*1995-05-181997-06-03Genetics Institute, Inc.BMP-15 compositions
HU222664B1 (en)1995-06-052003-09-29Genetics Institute, Llc Use of Bone Morphogenetic Protein (BMP) for Regeneration of Functional Link between Bone and tendon or Tape
US5902785A (en)*1995-06-061999-05-11Genetics Institute, Inc.Cartilage induction by bone morphogenetic proteins
US5700774A (en)*1996-03-261997-12-23Genetics Institute, Inc.Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
US5965403A (en)*1996-09-181999-10-12Genetics Institute, Inc.Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US6037519A (en)*1997-10-202000-03-14Sdgi Holdings, Inc.Ceramic fusion implants and compositions
EP0973926A1 (en)1997-03-142000-01-26Selective Genetics, Inc.Adenoviral vectors with modified tropism
US20010016646A1 (en)1998-03-202001-08-23David C. RuegerOsteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US7041641B2 (en)1997-03-202006-05-09Stryker CorporationOsteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
WO1998054572A1 (en)1997-05-301998-12-03Creative Biomolecules, Inc.Methods for evaluating tissue morphogenesis and activity
US5972368A (en)1997-06-111999-10-26Sdgi Holdings, Inc.Bone graft composites and spacers
AU745122B2 (en)1997-07-302002-03-14Emory UniversityNovel bone mineralization proteins, DNA, vectors, expression systems
US7923250B2 (en)1997-07-302011-04-12Warsaw Orthopedic, Inc.Methods of expressing LIM mineralization protein in non-osseous cells
US6891082B2 (en)*1997-08-012005-05-10The Johns Hopkins University School Of MedicineTransgenic non-human animals expressing a truncated activintype II receptor
US6696260B1 (en)*1997-08-012004-02-24The Johns Hopkins University School Of MedicineMethods to identify growth differentiation factor (GDF) binding proteins
AU8666398A (en)*1997-08-011999-02-22Johns Hopkins University School Of Medicine, TheMethods to identify growth differentiation factor (gdf) receptors
US20020052026A1 (en)1997-10-082002-05-02Steven M. VicikMethods of refolding proteins
US6511509B1 (en)1997-10-202003-01-28LifenetTextured bone allograft, method of making and using same
WO1999024057A2 (en)*1997-11-071999-05-20Genetics InstNeuronal uses of bmp-11
US6027917A (en)1997-12-102000-02-22Genetics Institute, Inc.Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US20030036629A1 (en)*1997-12-122003-02-20Barry FosterNovel tgf-beta protein purification methods
US6004937A (en)*1998-03-091999-12-21Genetics Institute, Inc.Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
US7147839B2 (en)1998-05-292006-12-12Curis, Inc.Methods for evaluating tissue morphogenesis and activity
WO2000006716A1 (en)*1998-07-282000-02-10The Johns Hopkins University School Of MedicineGrowth differentiation factor-11
AU5341999A (en)1998-08-062000-02-28Sdgi Holdings, Inc.Composited intervertebral bone spacers
US6849255B2 (en)*1998-08-182005-02-01Yissum Research Development Company Of The Hebrew University Of JerusalemMethods and compositions for enhancing cartilage repair
US6727224B1 (en)1999-02-012004-04-27Genetics Institute, Llc.Methods and compositions for healing and repair of articular cartilage
EP1181041A2 (en)*1999-04-302002-02-27Curis, Inc.Morphogen-induced enhancement of fertility
US7189392B1 (en)1999-10-152007-03-13Genetics Institute, LlcInjectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins
JP4672947B2 (en)1999-12-062011-04-20ウォーソー・オーソペディック・インコーポレーテッド Intervertebral disc treatment apparatus and method
US20030082233A1 (en)*2000-12-012003-05-01Lyons Karen M.Method and composition for modulating bone growth
US6752831B2 (en)2000-12-082004-06-22Osteotech, Inc.Biocompatible osteogenic band for repair of spinal disorders
US8758438B2 (en)2000-12-082014-06-24Warsaw Orthopedic, Inc.Implant for orthopedic applications
US7141392B2 (en)2001-01-092006-11-28Queen Mary And Westfield CollegeLatent fusion protein
GB0100551D0 (en)*2001-01-092001-02-21Queen Mary & Westfield CollegeProtein
TWI329129B (en)2001-02-082010-08-21Wyeth CorpModified and stabilized gdf propeptides and uses thereof
EP1790726B1 (en)*2001-02-082013-07-03Wyeth LLCModified and stabilized GDF propeptides and uses thereof
KR100420798B1 (en)*2001-02-102004-03-02(주)알에이싸이언스Peptide vector
US7226587B2 (en)2001-06-012007-06-05WyethCompositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en)2001-06-082006-12-01Wyeth CorpCalcium phosphate delivery vehicles for osteoinductive proteins
US7320789B2 (en)2001-09-262008-01-22WyethAntibody inhibitors of GDF-8 and uses thereof
US6798160B2 (en)*2001-11-022004-09-28Honda Giken Kogyo Kabushiki KaishaElectric working machine
KR100955410B1 (en)*2001-11-272010-05-06타키론 가부시기가이샤 Implant Materials and Manufacturing Method Thereof
CH695985A5 (en)*2002-01-212006-11-15Straumann Holding AgSurface-modified implants.
BR0307871A (en)2002-02-212005-04-12Wyeth Corp Folistatin Domain-Containing Proteins
US7192717B2 (en)2002-02-212007-03-20WyethGASP1: a follistatin domain containing protein
CN1665525A (en)*2002-05-172005-09-07惠氏公司Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
AU2003259765B2 (en)*2002-08-132009-01-22WyethPeptides as solubilizing excipients for transforming growth factor Beta proteins
EP1549747A4 (en)*2002-09-162006-08-23Wyeth CorpMetalloprotease activation of myostatin, and methods of modulating myostatin activity
AR047392A1 (en)2002-10-222006-01-18Wyeth Corp NEUTRALIZATION OF ANTIBODIES AGAINST GDF 8 AND ITS USE FOR SUCH PURPOSES
US20040223966A1 (en)*2002-10-252004-11-11Wolfman Neil M.ActRIIB fusion polypeptides and uses therefor
JP5110877B2 (en)2003-06-022012-12-26ワイス・エルエルシー Use of myostatin (GDF8) inhibitors in combination with corticosteroids to treat neuromuscular disorders
KR20060133961A (en)2003-09-122006-12-27와이어쓰 Injectable Calcium Phosphate Solid Rods and Pastes for Bone Formation Protein Delivery
EP1737734B1 (en)2004-03-102010-08-18Scil Technology GmbHCoated implants, their manufacturing and use thereof
EP1740609A2 (en)2004-04-272007-01-10Research Development FoundationAntagonism of tgf-beta superfamily receptor signaling
JP5201987B2 (en)2004-05-252013-06-05ストライカー コーポレイション Use of morphogenic proteins to treat cartilage defects
US7749268B2 (en)2004-05-262010-07-06Warsaw Orthopedic, Inc.Methods for treating the spine
BRPI0514253A (en)*2004-08-122008-06-03Wyeth Corp combination therapy for diabetes, obesity and cardiovascular disease using compositions containing gdf-8 inhibitors
US7473678B2 (en)2004-10-142009-01-06Biomimetic Therapeutics, Inc.Platelet-derived growth factor compositions and methods of use thereof
WO2006081379A1 (en)*2005-01-262006-08-03WyethUse of sfrps as markers of bmp activity
CA2601086A1 (en)*2005-03-232006-10-12WyethDetection of an immune response to gdf-8 modulating agents
AU2006230434A1 (en)*2005-03-302006-10-05WyethMethods for stimulating hair growth by administering BMPs
US8506646B2 (en)2005-04-292013-08-13Warsaw Orthopedic, Inc.Multi-purpose medical implant devices
US20060247790A1 (en)*2005-04-302006-11-02Mckay William FShaped osteochondral grafts and methods of using same
JP5052517B2 (en)2005-10-062012-10-17イーライ リリー アンド カンパニー Anti-myostatin antibody
UA92504C2 (en)2005-10-122010-11-10Эли Лилли Энд КомпаниAnti-myostatin monoclonal antibody
US8147860B2 (en)2005-12-062012-04-03Etex CorporationPorous calcium phosphate bone material
WO2007092622A2 (en)2006-02-092007-08-16Biomimetic Therapeutics, Inc.Compositions and methods for treating bone
JP5362554B2 (en)2006-05-172013-12-11ストライカー コーポレイション Use of soluble morphogenic proteins to treat cartilage defects
WO2008005427A2 (en)2006-06-302008-01-10Biomimetic Therapeutics, Inc.Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en)2006-06-302015-10-20Biomimetic Therapeutics, LlcCompositions and methods for treating the vertebral column
US8524265B2 (en)2006-08-172013-09-03Warsaw Orthopedic, Inc.Medical implant sheets useful for tissue regeneration
RS52787B (en)2006-09-052013-10-31Eli Lilly And CompanyAnti-myostatin antibodies
JP2008104401A (en)*2006-10-252008-05-08Kyoto Univ Method for in vitro proliferation of spermatogonial stem cells
AU2007234612B2 (en)2006-12-142013-06-27Johnson & Johnson Regenerative Therapeutics, LlcProtein stabilization formulations
ES2447516T3 (en)2006-12-212014-03-12Stryker Corporation Sustained release formulations comprising BMP-7 crystals
US7678764B2 (en)2007-06-292010-03-16Johnson & Johnson Regenerative Therapeutics, LlcProtein formulations for use at elevated temperatures
US8058237B2 (en)2007-08-072011-11-15Advanced Technologies & Regenerative Medicine, LLCStable composition of GDF-5 and method of storage
ES2474194T3 (en)2008-02-132014-07-08Keith Hruska PMO-7 for use in the treatment of neointimal hyperplasia
CN102026619A (en)2008-04-142011-04-20先进科技及再生医学有限责任公司Liquid buffered GDF-5 formulations
MX2011002555A (en)2008-09-092011-08-03Biomimetic Therapeutics IncPlatelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries.
US20100204124A1 (en)2009-02-122010-08-12Mary Elizabeth Pecquet GoadCompositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
CN102369016A (en)2009-02-122012-03-07史赛克公司Peripheral administration of proteins comprising members of the TGF-beta superfamily for the treatment of systemic disorders and diseases
WO2010110974A1 (en)2009-03-242010-09-30Stryker CorporationMethods and compositions for tissue engineering
US8609127B2 (en)2009-04-032013-12-17Warsaw Orthopedic, Inc.Medical implant with bioactive material and method of making the medical implant
US20110002897A1 (en)2009-06-112011-01-06Burnham Institute For Medical ResearchDirected differentiation of stem cells
US9399086B2 (en)2009-07-242016-07-26Warsaw Orthopedic, IncImplantable medical devices
US20110224138A1 (en)2009-09-092011-09-15Julie KropMethods for treating pain induced by injuries and diseases of an articular joint
US20110224410A1 (en)2009-09-172011-09-15Hile DavidBuffers for Controlling the pH of Bone Morphogenetic Proteins
WO2011087768A1 (en)2009-12-222011-07-21Stryker CorporationBmp-7 variants with reduced immunogenicity
NZ601559A (en)2010-02-222014-10-31Biomimetic Therapeutics LlcPlatelet-derived growth factor compositions and methods for the treatment of tendinopathies
WO2011139594A2 (en)2010-04-272011-11-10Medtronic, Inc.Artificial bursa for intra-articular drug delivery
CN103079585B (en)2010-08-202015-09-30惠氏有限责任公司Through the BMP of design
US9688735B2 (en)2010-08-202017-06-27Wyeth LlcDesigner osteogenic proteins
US8998925B2 (en)2011-06-202015-04-07Rdc Holdings, LlcFixation system for orthopedic devices
WO2012177759A1 (en)2011-06-202012-12-27Rdc Holdings, LlcSystem and method for repairing joints
EP2828289B1 (en)*2012-03-192020-02-26The Brigham and Women's Hospital, Inc.Growth differentiation factor (gdf) 11 for treatment of age-related cardiovascular condition
US10034945B2 (en)2012-07-132018-07-31Trustees Of Tufts CollegeSilk powder compaction for production of constructs with high mechanical strength and stiffness
US20160120945A1 (en)*2013-02-152016-05-05The Brigham And Women's Hospital, Inc.Thymic Regeneration
US10092627B2 (en)2013-04-082018-10-09President And Fellows Of Harvard CollegeMethods and compositions for rejuvenating skeletal muscle stem cells
AU2014253753B2 (en)2013-04-192017-03-30Theracell, Inc.Demineralized bone fibers having controlled geometry and shapes and methods thereof
WO2015070076A2 (en)*2013-11-082015-05-14President And Fellows Of Harvard CollegeMethods and compositions for rejuvenating neuromuscular junctions
US10017566B2 (en)2013-11-122018-07-10The Brigham And Women's Hospital, Inc.Growth differentiation factor (GDF) for treatment of diastolic heart failure
WO2016123583A1 (en)2015-01-292016-08-04Theracell, Inc.Demineralized bone fiber composition for use in minimally invasive surgery
EP3271380B1 (en)2015-03-172021-08-11ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A.Purification of bone morphogenetic proteins (bmps)
JP2018517527A (en)2015-06-172018-07-05ウォーソー・オーソペディック・インコーポレーテッド Implants containing oxysterol and methods of use thereof
EP3368016B1 (en)2015-10-262020-10-21President and Fellows of Harvard CollegeReduced and oxidized polysaccharides and methods of use thereof
WO2017120450A1 (en)2016-01-062017-07-13President And Fellows Of Harvard CollegeTreatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis
KR101810385B1 (en)*2016-02-042017-12-20주식회사 강스템바이오텍Composition comprising GDF11 and uses thereof
US10688222B2 (en)2016-11-212020-06-23Warsaw Orthopedic, Inc.Lyophilized moldable implants containing an oxysterol
US10639157B2 (en)2017-03-142020-05-05Theracell, Inc.Demineralized bone fiber composition for use in minimally invasive surgery
US11464888B2 (en)2017-06-122022-10-11Warsaw Orthopedic, Inc.Moldable formulations containing an oxysterol in an acellular tissue matrix
WO2019033082A1 (en)2017-08-112019-02-14Theracell, Inc.Demineralized bone fiber composition for augmentation of fixation
KR101893339B1 (en)*2017-09-192018-08-31주식회사 강스템바이오텍Composition comprising GDF11 and uses thereof
US11103618B2 (en)2018-02-222021-08-31Warsaw Orthopedic, Inc.Demineralized bone matrix having improved handling characteristics
CN109097425B (en)*2018-08-282022-06-07浙江康嘉基因技术有限公司Polypeptide and application of polypeptide as influenza vaccine immunologic adjuvant
WO2020163828A1 (en)2019-02-092020-08-13Theracell, Inc.Demineralized bone fiber implant compositions and methods for augmenting fixation in bone repair
US11498880B2 (en)2019-07-262022-11-15Warsaw Orthopedic, Inc.Calcium phosphate granules and methods of making them

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1991018047A2 (en)*1990-05-241991-11-28Genentech, Inc.Mammalian expression of the bmp-2 family
WO1991018098A1 (en)*1990-05-161991-11-28Genetics Institute, Inc.Bone and cartilage inductive proteins
WO1993000432A1 (en)*1991-06-251993-01-07Genetics Institute, Inc.Bmp-9 compositions
US5187076A (en)*1986-07-011993-02-16Genetics Institute, Inc.DNA sequences encoding BMP-6 proteins
WO1996001845A1 (en)*1994-07-081996-01-25The Johns Hopkins University School Of MedicineGrowth differentiation factor-11

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4419446A (en)1980-12-311983-12-06The United States Of America As Represented By The Department Of Health And Human ServicesRecombinant DNA process utilizing a papilloma virus DNA as a vector
DE3382562D1 (en)1982-09-241992-06-25Us Health ANIMAL TISSUE RECOVERY.
US4588684A (en)1983-04-261986-05-13Chiron Corporationa-Factor and its processing signals
NZ210699A (en)1984-01-041989-06-28Int Genetic EngIsolation of an osteogenic protein of the p3 immunologically related family
DK518384A (en)1984-01-311985-07-01Idaho Res Found VECTOR FOR THE MANUFACTURE OF A GENE PRODUCT IN INSECT CELLS, PROCEDURE FOR ITS MANUFACTURING AND ITS USE
CA1341617C (en)1984-06-082011-06-28Henry George BurgerInhibin isolated from ovarian follicular fluid
UA39161C2 (en)1984-07-062001-06-15Новартіс АгRecombinant protein of GM-CSF for increase in productION of granylocytes and macrophages by patients, vector and cdna coding it
EP0169016B2 (en)1984-07-162004-04-28Celtrix Pharmaceuticals, Inc.Polypeptide cartilage-inducing factors found in bone
ATE78515T1 (en)1984-10-051992-08-15Genentech Inc DNA, CELL CULTURES AND METHODS FOR HETEROLOGOUS PROTEIN SECRETION AND PERIPLASMIC PROTEIN RECOVERY.
US4740587A (en)*1985-07-181988-04-26The Salk Institute For Biological StudiesInhibin and method of purifying same
US5089396A (en)*1985-10-031992-02-18Genentech, Inc.Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5215893A (en)*1985-10-031993-06-01Genentech, Inc.Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ231899A (en)*1985-10-031991-07-26Genentech IncHuman or porcine inhibin peptide compositions and dna encoding them
US4798885A (en)1986-02-071989-01-17Genentech, Inc.Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4737578A (en)*1986-02-101988-04-12The Salk Institute For Biological StudiesHuman inhibin
IL83003A (en)*1986-07-011995-07-31Genetics InstOsteoinductive factors
US5013649A (en)1986-07-011991-05-07Genetics Institute, Inc.DNA sequences encoding osteoinductive products
ZA874681B (en)1986-07-011988-04-27Genetics InstNovel osteoinductive factors
US5106748A (en)1986-07-011992-04-21Genetics Institute, Inc.Dna sequences encoding 5 proteins
US5108922A (en)1986-07-011992-04-28Genetics Institute, Inc.DNA sequences encoding BMP-1 products
US5041538A (en)*1987-08-281991-08-20The Salk Institute For Biological StudiesMammalian follistatin
US5168150A (en)1988-03-171992-12-01Electronique Serge DassaultDevice for the processing of a magnetic-track ticket, especially an air transport ticket
US5071834A (en)1988-09-161991-12-10Genentech, Inc.Purified activin B composition
US5166190A (en)*1990-01-081992-11-24Genentech, Inc.Method for increasing fertility in males
EP0550625B1 (en)*1990-09-262003-11-05Genetics Institute, LLCBmp-5 derivatives
JP3356775B2 (en)*1990-11-302002-12-16セルトリックス ファーマシューティカルズ, インコーポレイテッド Use of osteogenic proteins for bone repair by co-combination with TGF-β
US5208219A (en)1991-02-141993-05-04Celtrix Pharmaceuticals Inc.Method for inducing bone growth
CA2102808A1 (en)*1991-05-101992-11-11Hanne BentzTargeted delivery of bone growth factors
US5171579A (en)*1991-10-111992-12-15Genetics Institute, Inc.Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
ATE238417T1 (en)*1991-11-042003-05-15Inst Genetics Llc RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE
PT653942E (en)1992-07-312003-11-28Curis Inc REGENERATION AND REPARATION OF MORPHOGENES INDUCED NERVES
EP1333035A3 (en)1993-03-192004-07-07The Johns Hopkins University School Of MedicineGrowth differentiation factor-8
ES2274157T3 (en)*1993-05-122007-05-16Genetics Institute, Llc BMP-11 COMPOSITIONS.
DE69433742T2 (en)*1993-05-122005-07-07Genetics Institute, LLC, Cambridge BMP-10 COMPOSITIONS
EP1716864A1 (en)*1993-08-262006-11-02Genetics Institute, LLCNeural regeneration using home bone morphogenetic proteins
US5545616A (en)*1994-09-221996-08-13Genentech, Inc.Method for predicting and/or preventing preterm labor
KR20000064752A (en)1996-03-222000-11-06더 제네랄 호스피탈 코포레이션 Administration of Polypeptide Growth Factor after Expression of Central Nervous System Ischemia or Trauma
JP3361278B2 (en)1997-12-262003-01-07シャープ株式会社 Reflection type liquid crystal display device, method for manufacturing the same, and method for manufacturing circuit board
US6004937A (en)*1998-03-091999-12-21Genetics Institute, Inc.Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5187076A (en)*1986-07-011993-02-16Genetics Institute, Inc.DNA sequences encoding BMP-6 proteins
WO1991018098A1 (en)*1990-05-161991-11-28Genetics Institute, Inc.Bone and cartilage inductive proteins
WO1991018047A2 (en)*1990-05-241991-11-28Genentech, Inc.Mammalian expression of the bmp-2 family
US5168050A (en)*1990-05-241992-12-01Genentech, Inc.Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
WO1993000432A1 (en)*1991-06-251993-01-07Genetics Institute, Inc.Bmp-9 compositions
WO1996001845A1 (en)*1994-07-081996-01-25The Johns Hopkins University School Of MedicineGrowth differentiation factor-11

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PARALKAR V M ET AL: "Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: Potentiation and binding to type IV collagen", JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 119, no. 6, 1992, pages 1721 - 1728, XP000576625, ISSN: 0021-9525*

Also Published As

Publication numberPublication date
ATE343635T1 (en)2006-11-15
ATE258984T1 (en)2004-02-15
PT1378572E (en)2007-01-31
FI955419A0 (en)1995-11-10
JP3681069B2 (en)2005-08-10
EP2272959A1 (en)2011-01-12
US5700911A (en)1997-12-23
HK1060898A1 (en)2004-08-27
NO954492D0 (en)1995-11-08
DE69433530D1 (en)2004-03-11
US20030166910A1 (en)2003-09-04
NO320119B1 (en)2005-10-31
EP1378572A1 (en)2004-01-07
US6437111B1 (en)2002-08-20
DE69434875D1 (en)2006-12-07
DE69434875T2 (en)2007-09-06
CA2161808C (en)2008-08-05
BR9406715A (en)1996-02-06
JP2005046155A (en)2005-02-24
ES2274157T3 (en)2007-05-16
EP0698094B1 (en)2004-02-04
KR960701996A (en)1996-03-28
DK0698094T3 (en)2004-05-03
US7175997B2 (en)2007-02-13
US6340668B1 (en)2002-01-22
AU6910594A (en)1994-12-12
ES2213745T3 (en)2004-09-01
PT698094E (en)2004-05-31
US5639638A (en)1997-06-17
EP0698094A1 (en)1996-02-28
US20060172391A1 (en)2006-08-03
EP1770161A2 (en)2007-04-04
NO954492L (en)1995-11-08
DK1378572T3 (en)2007-02-05
US20030083252A1 (en)2003-05-01
JPH09501304A (en)1997-02-10
DE69433530T2 (en)2005-01-05
WO1994026892A1 (en)1994-11-24
EP1378572B1 (en)2006-10-25
AU678582B2 (en)1997-06-05
FI119696B (en)2009-02-13
FI955419L (en)1996-01-08
KR100227406B1 (en)1999-12-01
OA10191A (en)1996-12-18
CA2161808A1 (en)1994-11-24

Similar Documents

PublicationPublication DateTitle
EP1770161A3 (en)BMP-11 compositions
EP0652107A3 (en)Parallel printing device with modular structure and relative process for the production thereof.
AU5936094A (en)Greeting and schedule integration arrangement
AU4225889A (en)Peptide synthesis method and solid support for use in the method
CA2170143A1 (en)Cell death regulator
AU3749493A (en)Process for the low-temperature air separation and air separation plant
AU8067394A (en)Benzylated wooden material and process for producing the same
AU1276095A (en)Improvements in or relating to fuses
AU2024797A (en)Improvement in the method and plant for manufacturing thermoplastic-resin parisons
AU6533294A (en)Seating arrangements for cycles, exercice cycles, other pedal-powered contrivances and the like contrivances
AU3749393A (en)Air separation plant and process for the low-temperature air separation
CA2087494A1 (en)Soluble ldl receptor, its production and use
AU8829391A (en)Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations
KR970000398B1 (en)Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
AU5837894A (en)Improvements in or relating to camera pedestals
AU6774694A (en)Taste-masking pharmaceutical compositions and methods for making the same
AU7622294A (en)Improvements in and relating to the shaping of articles
AU6669894A (en)Hybrid neuronal cell lines compositions and methods
ReneckerBioenergetics and behavior of moose (Alces alces) in the aspen-dominated boreal forest
EP0445021A3 (en)Tris acetyl-2",3",4'ethylidene-4",6"-beta-d-glucopyranosides, their production and use in the synthesis of ethylidene-beta-d-glucopyranosides of epipodophyllotoxin
AU7281296A (en)Dispersions containing polyurethanes with carbonyl groups in the keto function
AU7997794A (en)Improvements in connecting means
AU6197594A (en)Copolymer produced in two stages
HU9402646D0 (en)Anomere fluoro-ribosyl-amines
AU1485197A (en)Diamines in the treatment of arrhythmia

Legal Events

DateCodeTitleDescription
PUAIPublic reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text:ORIGINAL CODE: 0009012

17PRequest for examination filed

Effective date:20061024

ACDivisional application: reference to earlier application

Ref document number:0698094

Country of ref document:EP

Kind code of ref document:P

Ref document number:1378572

Country of ref document:EP

Kind code of ref document:P

AKDesignated contracting states

Kind code of ref document:A2

Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PUALSearch report despatched

Free format text:ORIGINAL CODE: 0009013

AKDesignated contracting states

Kind code of ref document:A3

Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AKXDesignation fees paid

Designated state(s):AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17QFirst examination report despatched

Effective date:20100326

STAAInformation on the status of an ep patent application or granted ep patent

Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18DApplication deemed to be withdrawn

Effective date:20130103


[8]ページ先頭

©2009-2025 Movatter.jp